Current status of minimally invasive esophagectomy for patients with esophageal cancer

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). However, advantages with regard to short-term outcome and oncological feasibility of MIE have not been adequately established. To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). A study group recently reported the results of the first multicenter randomized controlled trial (RCT) that compared MIE and OE. The incidence of pulmonary infection after surgery was markedly lower in the MIE group than in the OE group. Additional benefits of MIE included less operative blood loss, better postoperative patients' quality of life, and shorter hospital stay. However, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no RCTs to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer.

Original languageEnglish
Pages (from-to)513-521
Number of pages9
JournalGeneral Thoracic and Cardiovascular Surgery
Volume61
Issue number9
DOIs
Publication statusPublished - 2013 Sep

Fingerprint

Esophagectomy
Esophageal Neoplasms
Postoperative Hemorrhage
Thoracoscopy
Meta-Analysis
Length of Stay
Patient Care
Randomized Controlled Trials

Keywords

  • Complication
  • Esophageal cancer
  • Laparoscopy
  • Prone
  • Thoracoscopy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Current status of minimally invasive esophagectomy for patients with esophageal cancer. / Takeuchi, Hiroya; Kawakubo, Hirofumi; Kitagawa, Yuukou.

In: General Thoracic and Cardiovascular Surgery, Vol. 61, No. 9, 09.2013, p. 513-521.

Research output: Contribution to journalArticle

@article{7b16789e0b4647f5a47095a53d0cce92,
title = "Current status of minimally invasive esophagectomy for patients with esophageal cancer",
abstract = "Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). However, advantages with regard to short-term outcome and oncological feasibility of MIE have not been adequately established. To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). A study group recently reported the results of the first multicenter randomized controlled trial (RCT) that compared MIE and OE. The incidence of pulmonary infection after surgery was markedly lower in the MIE group than in the OE group. Additional benefits of MIE included less operative blood loss, better postoperative patients' quality of life, and shorter hospital stay. However, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no RCTs to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer.",
keywords = "Complication, Esophageal cancer, Laparoscopy, Prone, Thoracoscopy",
author = "Hiroya Takeuchi and Hirofumi Kawakubo and Yuukou Kitagawa",
year = "2013",
month = "9",
doi = "10.1007/s11748-013-0258-9",
language = "English",
volume = "61",
pages = "513--521",
journal = "General Thoracic and Cardiovascular Surgery",
issn = "1863-6705",
publisher = "Springer Japan",
number = "9",

}

TY - JOUR

T1 - Current status of minimally invasive esophagectomy for patients with esophageal cancer

AU - Takeuchi, Hiroya

AU - Kawakubo, Hirofumi

AU - Kitagawa, Yuukou

PY - 2013/9

Y1 - 2013/9

N2 - Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). However, advantages with regard to short-term outcome and oncological feasibility of MIE have not been adequately established. To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). A study group recently reported the results of the first multicenter randomized controlled trial (RCT) that compared MIE and OE. The incidence of pulmonary infection after surgery was markedly lower in the MIE group than in the OE group. Additional benefits of MIE included less operative blood loss, better postoperative patients' quality of life, and shorter hospital stay. However, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no RCTs to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer.

AB - Technical advancements and development of endoscopic equipment in thoracoscopic surgery have resulted in increase in the popularity of minimally invasive esophagectomy (MIE). However, advantages with regard to short-term outcome and oncological feasibility of MIE have not been adequately established. To date, a number of single-institution studies and several meta-analyses have demonstrated acceptable short-term outcomes of thoracoscopic esophagectomy for esophageal cancer, and the outcomes are comparable to those of conventional open esophagectomy (OE). A study group recently reported the results of the first multicenter randomized controlled trial (RCT) that compared MIE and OE. The incidence of pulmonary infection after surgery was markedly lower in the MIE group than in the OE group. Additional benefits of MIE included less operative blood loss, better postoperative patients' quality of life, and shorter hospital stay. However, the oncological benefit to patients undergoing MIE has not been scientifically proven because there have been no RCTs to verify the equivalency in long-term survival of patients undergoing MIE compared with that of patients undergoing OE. If future prospective studies indicate oncological benefits, MIE could truly become the standard care for patients with esophageal cancer.

KW - Complication

KW - Esophageal cancer

KW - Laparoscopy

KW - Prone

KW - Thoracoscopy

UR - http://www.scopus.com/inward/record.url?scp=84883853748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883853748&partnerID=8YFLogxK

U2 - 10.1007/s11748-013-0258-9

DO - 10.1007/s11748-013-0258-9

M3 - Article

VL - 61

SP - 513

EP - 521

JO - General Thoracic and Cardiovascular Surgery

JF - General Thoracic and Cardiovascular Surgery

SN - 1863-6705

IS - 9

ER -